EAM Investors, LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 108 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q1 2019$1,103,000
+2.9%
17,6960.0%0.27%
-6.9%
Q4 2018$1,072,000
+12.0%
17,696
+8.1%
0.29%
+104.9%
Q3 2018$957,000
-80.1%
16,368
-85.4%
0.14%
-77.4%
Q4 2015$4,807,000
+32.8%
111,866
+34.6%
0.63%
+9.8%
Q3 2015$3,619,000
+64.9%
83,114
+95.4%
0.57%
+123.0%
Q2 2015$2,195,000
-28.9%
42,534
-46.1%
0.26%
-28.0%
Q1 2015$3,089,000
+2.0%
78,901
+0.7%
0.36%
-15.4%
Q4 2014$3,027,000
+54.1%
78,371
+40.9%
0.42%
+5.8%
Q3 2014$1,964,00055,6360.40%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 285,259$16,685,0009.76%
JW Asset Management, LLC 73,649$4,308,0002.32%
THB ASSET MANAGEMENT 113,485$6,637,0000.81%
Eversept Partners, LP 21,900$1,280,9310.56%
EAM Global Investors LLC 20,642$1,207,0000.49%
RICE HALL JAMES & ASSOCIATES, LLC 181,690$10,627,0000.38%
Elk Creek Partners, LLC 114,230$6,681,0000.36%
ISTHMUS PARTNERS, LLC 19,525$1,142,0000.29%
PURA VIDA INVESTMENTS, LLC 20,160$1,179,0000.25%
CADENCE CAPITAL MANAGEMENT LLC 49,363$2,887,0000.16%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders